Schultzel Matthew, Saltzstein Sidney L, Downs Tracy M, Shimasaki Suzuho, Sanders Catherine, Sadler Georgia Robins
Rebecca and John Moores University of California-San Diego Cancer Center, San Diego, California 92093-0850, USA.
J Urol. 2008 Apr;179(4):1302-5; discussion 1305-6. doi: 10.1016/j.juro.2007.11.079. Epub 2008 Mar 4.
We examined the incidence rates of bladder cancer using California Cancer Registry data to determine if any trends exist.
Complete records of the 55,159 cases of invasive bladder cancer were examined from the original 92,677 bladder cancer cases recorded in the California Cancer Registry between 1988 and 2004.
California Cancer Registry data showed a universal late age peak in age specific incidence of bladder cancer in men and women, and across ethnic boundaries. The rate of annual increase in the percent of bladder cancer in individuals 85 years or older was increasing about 10 times as rapidly as the percent of the population that was 85 years or older (slope = 0.395 vs 0.0336). Furthermore, during all 17 years the proportion of patients 85 or older with bladder cancer was about twice that of patients with other cancers regardless of gender.
California Cancer Registry data illustrate a peak in the incidence of bladder cancer in individuals 85 years or older. However, to our knowledge there is no known explanation for this late peak in bladder cancer. With the rate of bladder cancer in the population 85 years or older increasing at a rapid pace, it is critical to encourage investigators to include this age group as they continue to search for causative factors and genetic contributors to bladder cancer as well as effective treatments.
我们利用加利福尼亚癌症登记处的数据研究膀胱癌的发病率,以确定是否存在任何趋势。
从1988年至2004年加利福尼亚癌症登记处记录的92,677例膀胱癌病例中,检查了55,159例浸润性膀胱癌的完整记录。
加利福尼亚癌症登记处的数据显示,无论男女,也无论种族界限,膀胱癌的年龄别发病率普遍在晚年达到峰值。85岁及以上个体中膀胱癌百分比的年增长率约为85岁及以上人口百分比年增长率的10倍(斜率分别为0.395和0.0336)。此外,在这17年中,85岁及以上膀胱癌患者的比例无论性别均约为其他癌症患者的两倍。
加利福尼亚癌症登记处的数据表明85岁及以上个体的膀胱癌发病率达到峰值。然而,据我们所知,目前尚无对膀胱癌这一晚期峰值的已知解释。鉴于85岁及以上人群中膀胱癌发病率快速上升,鼓励研究人员在继续寻找膀胱癌的致病因素、遗传因素以及有效治疗方法时纳入这一年龄组至关重要。